FEATURE ARTICLES
The race to the finish line for the first oral GLP-1 treatment for weight loss was won on Dec. 22, 2025, when the U.S Food and Drug Administration (FDA) approved oral Wegovy by Novo Nordisk as the first daily, oral GLP-1 pill for weight management.
- December 2025 — CDMO Opportunities And Threats Report
- 5 FDA Approval Categories In 2025
- A 2025 Pharma Look Back and Look Forward: Editor Style
- 2026 CDMO Forecast: The 7 Shifts Sponsors Need To Prepare For
- A Deeper Look At Pharma's Structural Supply Chain Vulnerability
- Top 7 AI Lessons Learned
- An AI Use Case in Pharma Process Optimization
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-1309776504-viral-inspection-laboratory-scientists]( "Next Generation Sequencing In Viral Safety Testing")
Next Generation Sequencing In Viral Safety TestingNext Generation Sequencing (NGS) offers a sensitive, high-throughput solution for detecting adventitious viral agents (AVAs), improving biopharmaceutical safety and accelerating regulatory-compliant product development.
-
Improving API Solubility3/3/2025
Ensuring adequate solubility is crucial for small molecule drugs' effectiveness. Find out how poor solubility remains a significant challenge, potentially hindering medications from reaching the market.
-
Change Management In Pharmaceutical Quality Control Laboratories10/29/2024
Gain expert insights into the driving forces behind change management, the associated obstacles within a QC lab, and best practices for guiding change when implementing new technology or procedures.
-
Accelerating Antibody-Drug Conjugate (ADC) Development10/29/2025
Explore how automated immunoassays help overcome ADC bioanalysis challenges, reducing hands-on time, improving throughput, and enabling multi-analyte workflows for more efficient assessments.
-
Continuous Flow — An Emerging Alternative5/16/2024
Gain insights on transitioning from batch to continuous flow processes, the benefits of continuous flow chemistry, and ensuring regulatory compliance with Quality by Design (QbD) principles.
-
Why Biopharma Breakthroughs Aren't Moving The Market10/20/2025
Biopharma is innovating fast but falling short commercially. Reveal key ecosystem gaps and five strategic actions to help strengthen resilience, accelerate performance, and futureproof organizations.
PHARMA ONLINE APP NOTES & CASE STUDIES
- HVLD Technology Pre-Filled Syringe Inspection
- Rapid Walkaway Solution For Assessing Viability In Cancer Organoids
- Pioneering Cancer Research Meets Unparalleled Veeva Vault Integration
- Explore A High-Performing Basal Medium And Feed Pairing
- Transforming A Liquid Protein Solution Into A Solid Oral Dosage Form
NEWSLETTER ARCHIVE
- 01.23.26 -- A Deeper Look At Pharma's Structural Supply Chain Vulnerability
- 01.22.26 -- Multiparticulates, Minitabs, And Microencapsulation For Improved Patient Adherence
- 01.22.26 -- Top 7 AI Lessons Learned
- 01.22.26 -- STREAM Edition: The Module Type Package Wants All Your Equipment To Start Talking
- 01.20.26 -- A 2025 Pharma Look Back And Look Forward: Editor Style
INDUSTRY NEWS
-
![FDA Logo on phone screen-GettyImages-2208861549]( "Høeg In, Pazdur Out At The FDA")
Høeg In, Pazdur Out At The FDAWhat an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Coating Place Announces Leadership Appointments To Support Next Phase Of Growth1/23/2026
As Coating Place celebrates its 50th anniversary, the company continues to build on its long-standing reputation as the industry leader in Wurster-based fluid bed technology for controlled release and taste masking applications.
-
Genentech To Double Its Investment At North Carolina Drug Manufacturing Facility1/22/2026
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced an expansion of its initial investment in a new Holly Springs, North Carolina manufacturing facility. The increased investment will more than double the total commitment for the company’s first-ever East Coast manufacturing facility to approximately $2 billion.
-
CDMO Alcami Expands RTP Footprint With New Durham Facility And Major Lab Expansion1/20/2026
Alcami Corporation, a leading U.S.-based contract development and manufacturing organization (CDMO), has acquired a 37,000-square-foot facility at 4620 Creekstone Drive in Durham, North Carolina. This $6.7 million investment strengthens Alcami's presence in the Research Triangle region and supports the company's continued expansion of advanced laboratory services.
-
Wilmington PharmaTech Appoints Seasoned Commercial Leader To Drive Growth1/16/2026
Wilmington PharmaTech (“WPT”), a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, today announced that it has appointed Mike Shearer to the role of Chief Commercial Officer, where he will play a pivotal role in driving growth, strengthening client partnerships, and furthering the organization’s position as a trusted partner for API development and manufacturing. Shearer will report to Hui-Yin “Harry” Li, Ph.D., WPT’s Founder and CEO.
-
Coating Place Secures Growth Capital Investment By 1315 Capital1/16/2026
Coating Place, a leading U.S.-based contract development and manufacturing organization (CDMO), has secured a strategic, growth investment from 1315 Capital, a Philadelphia-based healthcare-focused private equity firm.
